Greenland Mines (NASDAQ: GRML) has completed the acquisition of the Sarfartoq Nd-Pr Rare Earths Project in southwest Greenland, a transaction valued at $20 million in cash and $15 million in securities. The closing, effective September 1, 2026, positions the company to advance the project toward a Pre-Feasibility Study, with planned annual production of neodymium-praseodymium (NdPr) oxide representing approximately 34% of all NdPr oxide refined outside China at 2025 consumption levels during each of the project's nine scheduled operating years.
The acquisition underscores the strategic importance of diversifying rare earth supply chains, particularly for magnet metals critical to electric vehicles, wind turbines, and other clean energy technologies. An independent Initial Assessment based solely on the ST1 deposit estimates a high-case pre-tax net present value of approximately $2.05 billion and a pre-tax internal rate of return of 118.6%, including Indicated and Inferred Mineral Resources.
With the acquisition complete, Greenland Mines plans to initiate targeted infill drilling, pilot-scale metallurgical test work, mine engineering planning, environmental and social baseline studies, and drone-based magnetic surveys. These activities are designed to advance Sarfartoq toward a Pre-Feasibility Study, a critical step in de-risking the project and attracting further investment.
As part of the transaction, Neo Performance Materials became a strategic shareholder in Greenland Mines and retains offtake rights for up to 60% of future Sarfartoq ore or mineral concentrate production. This offtake agreement ensures a market for the project's output while supporting Neo's Silmet rare earth separation facility in Estonia, enhancing processing capabilities outside China.
The Sarfartoq project aligns with Greenland Mines' broader North Atlantic Critical Metals Corridor vision, which aims to link Greenlandic resources with allied downstream jurisdictions and industrial infrastructure. This strategy is intended to reduce reliance on Chinese rare earth processing, a key concern for Western governments and industries.
Greenland Mines operates with two divisions: Mining, focused on the Skaergaard Project in southeast Greenland and the Sarfartoq rare earths project, and Biotech, including Klotho's KLTO-202 primary indication for ALS. The company's strategy centers on building a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities.
The completion of this acquisition marks a significant milestone for Greenland Mines and the broader rare earth industry. By advancing Sarfartoq, the company aims to contribute to a more diversified and secure supply chain for critical minerals, which is essential for the global transition to clean energy and the growth of high-tech manufacturing.
For more information on the transaction, visit https://ibn.fm/rTIg0. To stay updated on Greenland Mines' latest news, see the company's newsroom at https://ibn.fm/GRML.
